More Post from the Author
- BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS
- Cathexis schliet den Verkauf der Yondr Group an DigitalBridge und La Caisse im Wert von 5,8 Mrd. USD erfolgreich ab
- Huawei uitgeroepen tot Challenger in Gartner Magic Quadrant for Backup & Data Protection Platforms
- EXPOSITION UNIVERSELLE AU JAPON : Pouvez-vous imaginer partir pour le Japon en voiture ?
- Broadridge Announces Expanded Roles for Senior Leaders
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS
- Cathexis schliet den Verkauf der Yondr Group an DigitalBridge und La Caisse im Wert von 5,8 Mrd. USD erfolgreich ab
- Huawei uitgeroepen tot Challenger in Gartner Magic Quadrant for Backup & Data Protection Platforms
- EXPOSITION UNIVERSELLE AU JAPON : Pouvez-vous imaginer partir pour le Japon en voiture ?
- Broadridge Announces Expanded Roles for Senior Leaders